Results from Phase IIb PADOVA and longer term follow-up data suggest clinical benefit on top of symptomatic treatment in ...

Results from Phase IIb PADOVA and longer term follow-up data suggest clinical benefit on top of symptomatic treatment in early-stage Parkinson's diseasePrasinezumab is a potential first-in-class anti- ...

Donald Trump is probably the most polarising leader amongst evangelical Christians that the world has seen. Millions of evangelicals who support him are convinced that Trump has been specially ...